These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 26144570

  • 1. Instability of IGF-IGFBP complex as a cause of the different performance of serum and EDTA-plasma after storage: EDTA-plasma is preferable for evaluating bioactive IGF especially in the mouse.
    Setoyama T, Miyamoto S, Nikaido M, Muto M, Chiba T.
    Growth Horm IGF Res; 2015 Oct; 25(5):227-31. PubMed ID: 26144570
    [Abstract] [Full Text] [Related]

  • 2. Influence of pre-analytical conditions on the measurement of components of the GH/IGF axis in rats.
    Bielohuby M, Popp S, Bidlingmaier M.
    Growth Horm IGF Res; 2013 Oct; 23(5):141-8. PubMed ID: 23773927
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
    Berrigan D, Potischman N, Dodd KW, Nicar M, McQuillan G, Lavigne JA, Barrett JC, Ballard-Barbash R.
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
    [Abstract] [Full Text] [Related]

  • 4. Interstitial fluid contains higher in vitro IGF bioactivity than serum: a study utilizing the suction blister technique.
    Espelund U, Søndergaard K, Bjerring P, Flyvbjerg A, Frystyk J.
    Growth Horm IGF Res; 2012 Dec; 22(6):234-9. PubMed ID: 22939216
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma.
    Lassarre C, Binoux M.
    Endocrinology; 1994 Mar; 134(3):1254-62. PubMed ID: 7509737
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.
    Lawrence JB, Conover CA, Haddad TC, Ingle JN, Reid JM, Ames MM, Suman VJ, Marks RS, Erlichman C, Hartmann LC.
    Clin Cancer Res; 1997 Oct; 3(10):1713-20. PubMed ID: 9815555
    [Abstract] [Full Text] [Related]

  • 7. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts.
    Fowlkes J, Freemark M.
    Endocrinology; 1992 Nov; 131(5):2071-6. PubMed ID: 1385096
    [Abstract] [Full Text] [Related]

  • 8. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
    Harris TG, Strickler HD, Yu H, Pollak MN, Monrad ES, Travin MI, Xue X, Rohan TE, Kaplan RC.
    Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
    [Abstract] [Full Text] [Related]

  • 9. Measurement of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 after delayed separation of whole blood samples.
    Hartog H, van der Graaf WT, Wesseling J, van der Veer E, Boezen HM.
    Clin Biochem; 2008 May; 41(7-8):636-9. PubMed ID: 18294961
    [Abstract] [Full Text] [Related]

  • 10. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES, Holly JM, Pollak MN, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [Abstract] [Full Text] [Related]

  • 11. Stability of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 measured by the IMMULITE automated chemiluminescence assay system in different blood specimens.
    Elmlinger MW, Zwirner M, Kühnel W.
    Clin Lab; 2005 Mar; 51(3-4):145-52. PubMed ID: 15819169
    [Abstract] [Full Text] [Related]

  • 12. Bioactive insulin-like growth factors as a possible molecular target for non-islet cell tumor hypoglycemia.
    Setoyama T, Miyamoto S, Horimatsu T, Funakoshi T, Nikaido M, Kodama Y, Minamiguchi S, Yamabata T, Muto M, Chiba T.
    Cancer Biol Ther; 2014 Mar; 15(12):1588-92. PubMed ID: 25535894
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factors and their binding proteins in children with IDDM.
    Wacharasindhu S, Srivuthana S, Aroonparkmongkol S.
    J Med Assoc Thai; 2002 Jan; 85(1):41-52. PubMed ID: 12075719
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilodalton IGFBP complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I.
    Lee CY, Rechler MM.
    Endocrinology; 1996 May; 137(5):2051-8. PubMed ID: 8612547
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [Abstract] [Full Text] [Related]

  • 20. Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation.
    Mohan S, Baylink DJ.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):637-47. PubMed ID: 7531716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.